Drug intelligence / Profile preview

Glutapro

Development stage: Unknown
Lead developer: Genspec Lifesciences
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

**Glutapro** is an oral, sugar-free nutraceutical sachet marketed by Genspec Lifesciences that combines l-glutamine with the probiotic yeast *Saccharomyces boulardii*. The available product information describes a 12 g sachet containing l-glutamine 10 g and *S. boulardii* 250 mg. L-glutamine is intended to support enterocyte metabolism and intestinal mucosal integrity, while *S. boulardii* is intended to support gut microbial balance and digestive health. It is marketed as supportive therapy for gastrointestinal health and recovery, rather than as a targeted molecular therapeutic. ([truemeds.in](https://www.truemeds.in/otc/glutapro-sugar-free-sachet-12gm-tm-posf1-000108))

Brand names: GlutaproGlutapro Sugar Free
Other names: L-glutamine + Saccharomyces boulardii

Beyond the preview

Go deeper on Glutapro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutapro.

Explore the full profile